Literature DB >> 9353142

Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection.

D Roccatello1, G Morsica, G Picciotto, G Cesano, R Ropolo, M T Bernardi, G Cacace, G Cavalli, L M Sena, A Lazzarin, G Piccoli, A Rifai.   

Abstract

The pathogenic mechanisms that lead to renal deposition of the cryoprecipitable IgM rheumatoid factor-IgG complexes in essential mixed cryoglobulinaemia (EMC) are unknown. Defective removal of cryoprecipitable complexes from the circulation has been postulated in EMC-associated nephritis. To test this hypothesis, the kinetics and fate of a trace dose of 123I-radiolabelled autologous cryoglobulins were analysed in 13 patients with EMC grouped according to renal involvement. The time course of radioactivity distribution in the blood and organ uptake were measured by gamma camera scintigraphy. In blood sampled 30-300 s after injection, only a minor fraction (< 15%) of the circulating cryoglobulins bound to the erythrocytes, suggesting the elimination mechanisms are independent of binding to CR1 on erythrocytes. The overall blood disappearance curve showed a fast (< or = 1 min) and slow (> 4 h) biphasic pattern. In patients with quiescent or mild nepthritis, the liver and to a lesser extent the spleen were the major organs that mediated the rapid uptake and processing of the cryoglobulins from the circulation. In contrast, patients with active mesangiocapillary glomerulonephritis showed significantly (P < 0.001) less hepatic uptake, low liver-to-precordium ratio, and slower processing of cryoglobulins, prolonged liver mean transit time, than quiescent patients or mild nephritis patients. To elucidate the role and influence of HCV infection in the pathogenesis of EMC-nephritis, sera and cryoglobulins from all patients were assayed for HCV. None of the control group cases without nephritis showed any evidence of HCV-RNA in serum or cryoglobulin pellet. In contrast, all 10 EMC-nephritis patients' sera, and eight corresponding cryoglobulin pellets contained HCV-RNA. Collectively, these findings suggest an impaired reticuloendothelial system removal of IgM-IgG-HCV complexes may underlie their renal deposition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353142      PMCID: PMC1904798          DOI: 10.1046/j.1365-2249.1997.4751383.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

1.  Anti-C1q antibodies in hepatitis C virus infection.

Authors:  D Saadoun; S Sadallah; M Trendelenburg; N Limal; D Sene; J C Piette; J A Schifferli; P Cacoub
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

2.  Effect of hepatitis C virus coinfection on humoral immune alterations in naïve HIV-infected adults on HAART: a three year follow-up study.

Authors:  Natalia Soriano-Sarabia; Manuel Leal; Carmen Delgado; Sonia Molina-Pinelo; Beatriz De Felipe; Ezequiel Ruiz-Mateos; Armando Sánchez-Quijano; Eduardo Lissen; Alejandro Vallejo
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

Review 3.  Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.

Authors:  Dario Roccatello; Simone Baldovino; Daniela Rossi; Osvaldo Giachino; Morteza Mansouri; Carla Naretto; Debora Di Simone; Simona Francica; Roberto Cavallo; Mirella Alpa; Franca Napoli; Luigi M Sena
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

4.  Rituximab in cryoglobulinemic peripheral neuropathy.

Authors:  Roberto Cavallo; Dario Roccatello; Elisa Menegatti; Carla Naretto; Franca Napoli; Simone Baldovino
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

Review 5.  Understanding the Cryoglobulinemias.

Authors:  Alejandro Fuentes; Claudia Mardones; Paula I Burgos
Journal:  Curr Rheumatol Rep       Date:  2019-11-19       Impact factor: 4.686

Review 6.  Cryoglobulin Test and Cryoglobulinemia Hepatitis C-Virus Related.

Authors:  Francesca Gulli; Stefano Angelo Santini; Cecilia Napodano; Patrizia Bottoni; Krizia Pocino; Gian Ludovico Rapaccini; Umberto Basile
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

Review 7.  The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.

Authors:  Dario Roccatello; Savino Sciascia; Daniela Rossi; Laura Solfietti; Roberta Fenoglio; Elisa Menegatti; Simone Baldovino
Journal:  Oncotarget       Date:  2017-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.